Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078367805> ?p ?o ?g. }
Showing items 1 to 97 of
97
with 100 items per page.
- W2078367805 endingPage "354" @default.
- W2078367805 startingPage "351" @default.
- W2078367805 abstract "Although the efficacy of infliximab in Crohn's disease (CD) has been demonstrated, its safety profile has yet to be established. Autoimmune adverse events such as human anti-chimeric antibodies and the development of antinuclear antibodies (ANAs) have been notified, but the true incidence and clinical relevance of the latter is still unknown.To evaluate the changes in ANA status in CD patients treated with infliximab and the clinical evolution of those who are ANA positive.The ANA status of 36 CD patients treated with infliximab was determined at baseline and 6 weeks after the initial infliximab infusion. Patients were followed up monthly. In the case of infliximab re-treatment, ANA status was again evaluated. Twenty-eight patients (78%) were treated concomitantly with immunosuppressants.Eight patients (22%) were ANA positive at baseline; none developed anti-double-stranded DNA antibodies (aDNAds) at week 6. Three of them were re-treated: there were increasing ANA titres in all cases and developing aDNAds in two. Only six of 28 patients who were ANA negative at baseline changed their ANA status at week 6, but none developed aDNAds. One of them was retreated showing a further increase in ANA titre and developing aDNAds at high titre. No patient presented lupus-like syndrome.Only a few CD patients treated with infliximab and immunosuppressants develop ANAs. This condition is not associated with aDNAds and/or lupus-like syndrome in the majority of cases." @default.
- W2078367805 created "2016-06-24" @default.
- W2078367805 creator A5028294586 @default.
- W2078367805 creator A5032022974 @default.
- W2078367805 creator A5053481644 @default.
- W2078367805 creator A5064167457 @default.
- W2078367805 creator A5070475894 @default.
- W2078367805 creator A5079272254 @default.
- W2078367805 creator A5085137667 @default.
- W2078367805 date "2003-04-01" @default.
- W2078367805 modified "2023-10-18" @default.
- W2078367805 title "Development of antinuclear antibodies and its clinical impact in patients with Crohn's disease treated with chimeric monoclonal anti-TNFα antibodies (infliximab)" @default.
- W2078367805 cites W1969916200 @default.
- W2078367805 cites W1971331540 @default.
- W2078367805 cites W2021446933 @default.
- W2078367805 cites W2024162533 @default.
- W2078367805 cites W2043671977 @default.
- W2078367805 cites W2063115128 @default.
- W2078367805 cites W2067192692 @default.
- W2078367805 cites W2069644264 @default.
- W2078367805 cites W2140296827 @default.
- W2078367805 cites W2321453230 @default.
- W2078367805 cites W2326330820 @default.
- W2078367805 cites W4237551299 @default.
- W2078367805 doi "https://doi.org/10.1097/00042737-200304000-00003" @default.
- W2078367805 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12655253" @default.
- W2078367805 hasPublicationYear "2003" @default.
- W2078367805 type Work @default.
- W2078367805 sameAs 2078367805 @default.
- W2078367805 citedByCount "38" @default.
- W2078367805 countsByYear W20783678052012 @default.
- W2078367805 countsByYear W20783678052013 @default.
- W2078367805 countsByYear W20783678052014 @default.
- W2078367805 countsByYear W20783678052015 @default.
- W2078367805 countsByYear W20783678052021 @default.
- W2078367805 crossrefType "journal-article" @default.
- W2078367805 hasAuthorship W2078367805A5028294586 @default.
- W2078367805 hasAuthorship W2078367805A5032022974 @default.
- W2078367805 hasAuthorship W2078367805A5053481644 @default.
- W2078367805 hasAuthorship W2078367805A5064167457 @default.
- W2078367805 hasAuthorship W2078367805A5070475894 @default.
- W2078367805 hasAuthorship W2078367805A5079272254 @default.
- W2078367805 hasAuthorship W2078367805A5085137667 @default.
- W2078367805 hasConcept C126322002 @default.
- W2078367805 hasConcept C149443304 @default.
- W2078367805 hasConcept C159654299 @default.
- W2078367805 hasConcept C163764329 @default.
- W2078367805 hasConcept C197934379 @default.
- W2078367805 hasConcept C203014093 @default.
- W2078367805 hasConcept C2776912625 @default.
- W2078367805 hasConcept C2777138892 @default.
- W2078367805 hasConcept C2778260677 @default.
- W2078367805 hasConcept C2779134260 @default.
- W2078367805 hasConcept C2779280984 @default.
- W2078367805 hasConcept C2780132546 @default.
- W2078367805 hasConcept C542903549 @default.
- W2078367805 hasConcept C70917649 @default.
- W2078367805 hasConcept C71924100 @default.
- W2078367805 hasConcept C90924648 @default.
- W2078367805 hasConceptScore W2078367805C126322002 @default.
- W2078367805 hasConceptScore W2078367805C149443304 @default.
- W2078367805 hasConceptScore W2078367805C159654299 @default.
- W2078367805 hasConceptScore W2078367805C163764329 @default.
- W2078367805 hasConceptScore W2078367805C197934379 @default.
- W2078367805 hasConceptScore W2078367805C203014093 @default.
- W2078367805 hasConceptScore W2078367805C2776912625 @default.
- W2078367805 hasConceptScore W2078367805C2777138892 @default.
- W2078367805 hasConceptScore W2078367805C2778260677 @default.
- W2078367805 hasConceptScore W2078367805C2779134260 @default.
- W2078367805 hasConceptScore W2078367805C2779280984 @default.
- W2078367805 hasConceptScore W2078367805C2780132546 @default.
- W2078367805 hasConceptScore W2078367805C542903549 @default.
- W2078367805 hasConceptScore W2078367805C70917649 @default.
- W2078367805 hasConceptScore W2078367805C71924100 @default.
- W2078367805 hasConceptScore W2078367805C90924648 @default.
- W2078367805 hasIssue "4" @default.
- W2078367805 hasLocation W20783678051 @default.
- W2078367805 hasLocation W20783678052 @default.
- W2078367805 hasOpenAccess W2078367805 @default.
- W2078367805 hasPrimaryLocation W20783678051 @default.
- W2078367805 hasRelatedWork W1588288904 @default.
- W2078367805 hasRelatedWork W1963997208 @default.
- W2078367805 hasRelatedWork W2000908943 @default.
- W2078367805 hasRelatedWork W2085326056 @default.
- W2078367805 hasRelatedWork W2116538321 @default.
- W2078367805 hasRelatedWork W2117102124 @default.
- W2078367805 hasRelatedWork W2131408481 @default.
- W2078367805 hasRelatedWork W2165607549 @default.
- W2078367805 hasRelatedWork W2423402760 @default.
- W2078367805 hasRelatedWork W2755604283 @default.
- W2078367805 hasVolume "15" @default.
- W2078367805 isParatext "false" @default.
- W2078367805 isRetracted "false" @default.
- W2078367805 magId "2078367805" @default.
- W2078367805 workType "article" @default.